Loading…

Cardiovascular disease/stroke risk stratification in deep learning framework: a review

The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular diagnosis and therapy 2023-06, Vol.12 (3), p.557-598
Main Authors: Bhagawati, Mrinalini, Paul, Sudip, Agarwal, Sushant, Protogeron, Athanasios, Sfikakis, Petros P., Kitas, George D., Khanna, Narendra N., Ruzsa, Zoltan, Sharma, Aditya M., Tomazu, Omerzu, Turk, Monika, Faa, Gavino, Tsoulfas, George, Laird, John R., Rathore, Vijay, Johri, Amer M., Viskovic, Klaudija, Kalra, Manudeep, Balestrieri, Antonella, Nicolaides, Andrew, Singh, Inder M., Chaturvedi, Seemant, Paraskevas, Kosmas I., Fouda, Mostafa M., Saba, Luca, Suri, Jasjit S.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3
cites
container_end_page 598
container_issue 3
container_start_page 557
container_title Cardiovascular diagnosis and therapy
container_volume 12
creator Bhagawati, Mrinalini
Paul, Sudip
Agarwal, Sushant
Protogeron, Athanasios
Sfikakis, Petros P.
Kitas, George D.
Khanna, Narendra N.
Ruzsa, Zoltan
Sharma, Aditya M.
Tomazu, Omerzu
Turk, Monika
Faa, Gavino
Tsoulfas, George
Laird, John R.
Rathore, Vijay
Johri, Amer M.
Viskovic, Klaudija
Kalra, Manudeep
Balestrieri, Antonella
Nicolaides, Andrew
Singh, Inder M.
Chaturvedi, Seemant
Paraskevas, Kosmas I.
Fouda, Mostafa M.
Saba, Luca
Suri, Jasjit S.
description The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.
doi_str_mv 10.21037/cdt-22-438
format article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMoWGpP_gO5y9pksp9eRIpfUPCiXkM2mdTY7aYk2y3-90YrBecw8-Axj8ePkEvOroEzUc21GTKALBf1CZkAgMhEWbLToy7gnMxi_GRp6oLXJUzI-0IF4_yoot51KlDjIqqI8zgEv0YaXFzTpNXgrNNp-566nhrELe1Qhd71K2qD2uDeh_UNVTTg6HB_Qc6s6iLO_u6UvD3cvy6esuXL4_PibplpUcOQ8apShbBtYaxAhZADx1w02BjkrC1Fk1vQRmiDqqpNVTfMaqiMzlnR_phiSm4Pudtdu0GjsU9dO7kNbqPCl_TKyf9O7z7kyo8yAeNFDk1KuDok6OBjDGiPz5zJX64ycZUAMnEV32tnbqg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><source>PubMed Central</source><creator>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</creator><creatorcontrib>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</creatorcontrib><description>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</description><identifier>ISSN: 2223-3652</identifier><identifier>EISSN: 2223-3660</identifier><identifier>DOI: 10.21037/cdt-22-438</identifier><language>eng</language><publisher>AME Publishing Company</publisher><subject>Review</subject><ispartof>Cardiovascular diagnosis and therapy, 2023-06, Vol.12 (3), p.557-598</ispartof><rights>2023 Cardiovascular Diagnosis and Therapy. All rights reserved. 2023 Cardiovascular Diagnosis and Therapy.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315429/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315429/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Bhagawati, Mrinalini</creatorcontrib><creatorcontrib>Paul, Sudip</creatorcontrib><creatorcontrib>Agarwal, Sushant</creatorcontrib><creatorcontrib>Protogeron, Athanasios</creatorcontrib><creatorcontrib>Sfikakis, Petros P.</creatorcontrib><creatorcontrib>Kitas, George D.</creatorcontrib><creatorcontrib>Khanna, Narendra N.</creatorcontrib><creatorcontrib>Ruzsa, Zoltan</creatorcontrib><creatorcontrib>Sharma, Aditya M.</creatorcontrib><creatorcontrib>Tomazu, Omerzu</creatorcontrib><creatorcontrib>Turk, Monika</creatorcontrib><creatorcontrib>Faa, Gavino</creatorcontrib><creatorcontrib>Tsoulfas, George</creatorcontrib><creatorcontrib>Laird, John R.</creatorcontrib><creatorcontrib>Rathore, Vijay</creatorcontrib><creatorcontrib>Johri, Amer M.</creatorcontrib><creatorcontrib>Viskovic, Klaudija</creatorcontrib><creatorcontrib>Kalra, Manudeep</creatorcontrib><creatorcontrib>Balestrieri, Antonella</creatorcontrib><creatorcontrib>Nicolaides, Andrew</creatorcontrib><creatorcontrib>Singh, Inder M.</creatorcontrib><creatorcontrib>Chaturvedi, Seemant</creatorcontrib><creatorcontrib>Paraskevas, Kosmas I.</creatorcontrib><creatorcontrib>Fouda, Mostafa M.</creatorcontrib><creatorcontrib>Saba, Luca</creatorcontrib><creatorcontrib>Suri, Jasjit S.</creatorcontrib><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><title>Cardiovascular diagnosis and therapy</title><description>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</description><subject>Review</subject><issn>2223-3652</issn><issn>2223-3660</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEQxYMoWGpP_gO5y9pksp9eRIpfUPCiXkM2mdTY7aYk2y3-90YrBecw8-Axj8ePkEvOroEzUc21GTKALBf1CZkAgMhEWbLToy7gnMxi_GRp6oLXJUzI-0IF4_yoot51KlDjIqqI8zgEv0YaXFzTpNXgrNNp-566nhrELe1Qhd71K2qD2uDeh_UNVTTg6HB_Qc6s6iLO_u6UvD3cvy6esuXL4_PibplpUcOQ8apShbBtYaxAhZADx1w02BjkrC1Fk1vQRmiDqqpNVTfMaqiMzlnR_phiSm4Pudtdu0GjsU9dO7kNbqPCl_TKyf9O7z7kyo8yAeNFDk1KuDok6OBjDGiPz5zJX64ycZUAMnEV32tnbqg</recordid><startdate>20230630</startdate><enddate>20230630</enddate><creator>Bhagawati, Mrinalini</creator><creator>Paul, Sudip</creator><creator>Agarwal, Sushant</creator><creator>Protogeron, Athanasios</creator><creator>Sfikakis, Petros P.</creator><creator>Kitas, George D.</creator><creator>Khanna, Narendra N.</creator><creator>Ruzsa, Zoltan</creator><creator>Sharma, Aditya M.</creator><creator>Tomazu, Omerzu</creator><creator>Turk, Monika</creator><creator>Faa, Gavino</creator><creator>Tsoulfas, George</creator><creator>Laird, John R.</creator><creator>Rathore, Vijay</creator><creator>Johri, Amer M.</creator><creator>Viskovic, Klaudija</creator><creator>Kalra, Manudeep</creator><creator>Balestrieri, Antonella</creator><creator>Nicolaides, Andrew</creator><creator>Singh, Inder M.</creator><creator>Chaturvedi, Seemant</creator><creator>Paraskevas, Kosmas I.</creator><creator>Fouda, Mostafa M.</creator><creator>Saba, Luca</creator><creator>Suri, Jasjit S.</creator><general>AME Publishing Company</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230630</creationdate><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><author>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Bhagawati, Mrinalini</creatorcontrib><creatorcontrib>Paul, Sudip</creatorcontrib><creatorcontrib>Agarwal, Sushant</creatorcontrib><creatorcontrib>Protogeron, Athanasios</creatorcontrib><creatorcontrib>Sfikakis, Petros P.</creatorcontrib><creatorcontrib>Kitas, George D.</creatorcontrib><creatorcontrib>Khanna, Narendra N.</creatorcontrib><creatorcontrib>Ruzsa, Zoltan</creatorcontrib><creatorcontrib>Sharma, Aditya M.</creatorcontrib><creatorcontrib>Tomazu, Omerzu</creatorcontrib><creatorcontrib>Turk, Monika</creatorcontrib><creatorcontrib>Faa, Gavino</creatorcontrib><creatorcontrib>Tsoulfas, George</creatorcontrib><creatorcontrib>Laird, John R.</creatorcontrib><creatorcontrib>Rathore, Vijay</creatorcontrib><creatorcontrib>Johri, Amer M.</creatorcontrib><creatorcontrib>Viskovic, Klaudija</creatorcontrib><creatorcontrib>Kalra, Manudeep</creatorcontrib><creatorcontrib>Balestrieri, Antonella</creatorcontrib><creatorcontrib>Nicolaides, Andrew</creatorcontrib><creatorcontrib>Singh, Inder M.</creatorcontrib><creatorcontrib>Chaturvedi, Seemant</creatorcontrib><creatorcontrib>Paraskevas, Kosmas I.</creatorcontrib><creatorcontrib>Fouda, Mostafa M.</creatorcontrib><creatorcontrib>Saba, Luca</creatorcontrib><creatorcontrib>Suri, Jasjit S.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular diagnosis and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhagawati, Mrinalini</au><au>Paul, Sudip</au><au>Agarwal, Sushant</au><au>Protogeron, Athanasios</au><au>Sfikakis, Petros P.</au><au>Kitas, George D.</au><au>Khanna, Narendra N.</au><au>Ruzsa, Zoltan</au><au>Sharma, Aditya M.</au><au>Tomazu, Omerzu</au><au>Turk, Monika</au><au>Faa, Gavino</au><au>Tsoulfas, George</au><au>Laird, John R.</au><au>Rathore, Vijay</au><au>Johri, Amer M.</au><au>Viskovic, Klaudija</au><au>Kalra, Manudeep</au><au>Balestrieri, Antonella</au><au>Nicolaides, Andrew</au><au>Singh, Inder M.</au><au>Chaturvedi, Seemant</au><au>Paraskevas, Kosmas I.</au><au>Fouda, Mostafa M.</au><au>Saba, Luca</au><au>Suri, Jasjit S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</atitle><jtitle>Cardiovascular diagnosis and therapy</jtitle><date>2023-06-30</date><risdate>2023</risdate><volume>12</volume><issue>3</issue><spage>557</spage><epage>598</epage><pages>557-598</pages><issn>2223-3652</issn><eissn>2223-3660</eissn><abstract>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</abstract><pub>AME Publishing Company</pub><doi>10.21037/cdt-22-438</doi><tpages>42</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2223-3652
ispartof Cardiovascular diagnosis and therapy, 2023-06, Vol.12 (3), p.557-598
issn 2223-3652
2223-3660
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429
source PubMed Central
subjects Review
title Cardiovascular disease/stroke risk stratification in deep learning framework: a review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T02%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20disease/stroke%20risk%20stratification%20in%20deep%20learning%20framework:%20a%20review&rft.jtitle=Cardiovascular%20diagnosis%20and%20therapy&rft.au=Bhagawati,%20Mrinalini&rft.date=2023-06-30&rft.volume=12&rft.issue=3&rft.spage=557&rft.epage=598&rft.pages=557-598&rft.issn=2223-3652&rft.eissn=2223-3660&rft_id=info:doi/10.21037/cdt-22-438&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true